CD80 and neoplasm: Additionally, IL-18 also induces the expression of CD80, CD86, HLA-DR and HLA-DQ on NK cells derived from cancer patients, suggesting that IL-18 conferred NK cells on an APC-like phenotype, which indicates increased recognition and responsiveness to tumour antigens [68].